Quick Takeaways
- 1Globe Capital LLC filed SCHEDULE 13D/A for SINOVAC BIOTECH LTD Common Shares, par value $0.001 per share (SVA).
- Disclosed ownership: 32%.
- Date of event: 27 Jun 2025.
1Globe Capital LLC - 27 Jun 2025 SCHEDULE 13D/A Report for SINOVAC BIOTECH LTD Common Shares, par value $0.001 per share (SVA)
- Filing Manager
- 1Globe Capital LLC
- Reporting Manager
- 1Globe Capital LLC
- Symbol
- SVA
- Shares outstanding
- 57,322,957 shares
- Disclosed Ownership
- 18,515,315 shares
- Ownership
- 32%
- Form type
- SCHEDULE 13D/A
- Filing time
- 03 Jul 2025, 21:47:20 UTC
- Date of event
- 27 Jun 2025
- Next filing
- 07 Jul 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"1Globe Capital LLC disclosed 32% ownership in SINOVAC BIOTECH LTD Common Shares, par value $0.001 per share (SVA) on 27 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Jul 2025, 21:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| 1Globe Capital LLC | 32% | 18,515,315 | 6,812,855 | 11,702,460 | /s/ Chiang Li | Chairman | 0001562189 |
| 1Globe Biomedical (Hong Kong) Company Limited | 32% | 18,515,315 | 6,812,855 | 11,702,460 | /s/ Chiang Li | Chairman |